These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 8147544)
1. A case-management system for coronary risk factor modification after acute myocardial infarction. DeBusk RF; Miller NH; Superko HR; Dennis CA; Thomas RJ; Lew HT; Berger WE; Heller RS; Rompf J; Gee D; Kraemer HC; Bandura A; Ghandour G; Clark M; Shah RV; Fisher L; Taylor CB Ann Intern Med; 1994 May; 120(9):721-9. PubMed ID: 8147544 [TBL] [Abstract][Full Text] [Related]
2. Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study. Pedersen TR; Jahnsen KE; Vatn S; Semb AG; Kontny F; Zalmai A; Nerdrum T Clin Ther; 2000 Aug; 22(8):949-60. PubMed ID: 10972631 [TBL] [Abstract][Full Text] [Related]
3. Smoking, low density lipoprotein cholesterol, fibrinogen and myocardial infarction before 41 years of age: a Danish case-control study. von Eyben FE; Mouritsen E; Holm J; Montvilas P; Dimcevski G; Helleberg I; Kristensen L; Suciu G; von Eyben R J Cardiovasc Risk; 2002 Jun; 9(3):171-8. PubMed ID: 12202840 [TBL] [Abstract][Full Text] [Related]
4. Improving lipid evaluation and management in medicare patients hospitalized for acute myocardial infarction. Malach M; Quinley J; Imperato PJ; Wallen M Arch Intern Med; 2001 Mar; 161(6):839-44. PubMed ID: 11268226 [TBL] [Abstract][Full Text] [Related]
5. Smoking cessation after acute myocardial infarction: effects of a nurse-managed intervention. Taylor CB; Houston-Miller N; Killen JD; DeBusk RF Ann Intern Med; 1990 Jul; 113(2):118-23. PubMed ID: 2360750 [TBL] [Abstract][Full Text] [Related]
6. Improving outcomes after myocardial infarction: a randomized controlled trial evaluating effects of a telephone follow-up intervention. Hanssen TA; Nordrehaug JE; Eide GE; Hanestad BR Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):429-37. PubMed ID: 17568244 [TBL] [Abstract][Full Text] [Related]
7. A community-wide survey of physician practices and attitudes toward cholesterol management in patients with recent acute myocardial infarction. Yarzebski J; Bujor CF; Goldberg RJ; Spencer F; Lessard D; Gore JM Arch Intern Med; 2002 Apr; 162(7):797-804. PubMed ID: 11926854 [TBL] [Abstract][Full Text] [Related]
8. Does nurse-based case management for aged myocardial infarction patients improve risk factors, physical functioning and mental health? The KORINNA trial. Hunger M; Kirchberger I; Holle R; Seidl H; Kuch B; Wende R; Meisinger C Eur J Prev Cardiol; 2015 Apr; 22(4):442-50. PubMed ID: 24523431 [TBL] [Abstract][Full Text] [Related]
10. Smoking cessation in hospitalized patients. Results of a randomized trial. Miller NH; Smith PM; DeBusk RF; Sobel DS; Taylor CB Arch Intern Med; 1997 Feb; 157(4):409-15. PubMed ID: 9046892 [TBL] [Abstract][Full Text] [Related]
11. Achieving cholesterol target in a managed care organization (ACTION) trial. Straka RJ; Taheri R; Cooper SL; Smith JC Pharmacotherapy; 2005 Mar; 25(3):360-71. PubMed ID: 15843283 [TBL] [Abstract][Full Text] [Related]
12. Persistent smokers after myocardial infarction: a group that requires special attention. Rallidis LS; Hamodraka ES; Foulidis VO; Pavlakis GP Int J Cardiol; 2005 Apr; 100(2):241-5. PubMed ID: 15823631 [TBL] [Abstract][Full Text] [Related]
13. Brief intervention during hospital admission to help patients to give up smoking after myocardial infarction and bypass surgery: randomised controlled trial. Hajek P; Taylor TZ; Mills P BMJ; 2002 Jan; 324(7329):87-9. PubMed ID: 11786452 [TBL] [Abstract][Full Text] [Related]
14. Individual responses to a cholesterol-lowering diet in 50 men with moderate hypercholesterolemia. Denke MA; Grundy SM Arch Intern Med; 1994 Feb; 154(3):317-25. PubMed ID: 8297199 [TBL] [Abstract][Full Text] [Related]
16. Nurse case management of hypercholesterolemia in patients with coronary heart disease: results of a randomized clinical trial. Allen JK; Blumenthal RS; Margolis S; Young DR; Miller ER; Kelly K Am Heart J; 2002 Oct; 144(4):678-86. PubMed ID: 12360165 [TBL] [Abstract][Full Text] [Related]
17. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57). Desai NR; Giugliano RP; Zhou J; Kohli P; Somaratne R; Hoffman E; Liu T; Scott R; Wasserman SM; Sabatine MS J Am Coll Cardiol; 2014 Feb; 63(5):430-3. PubMed ID: 24161333 [TBL] [Abstract][Full Text] [Related]
19. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN. J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296 [TBL] [Abstract][Full Text] [Related]